hepatocellular carcinoma
Novel First-Line Therapy’s OS Benefit for Liver Cancer Persists
Long-term overall survival in hepatocellular carcinoma with tremelimumab plus durvalumab treatment is durable, ...
NOVEMBER 9, 2023
Evidence Grows for Avoiding Biopsy in Hepatocellular Carcinoma
A new study supports exhausting noninvasive methods to diagnose hepatocellular carcinoma (HCC) before attempting ...
JANUARY 27, 2021
Load more